Guardant Health, Inc. (GH) Form 8-K — Nov 3, 2026
Guardant Health appointed Kevin Sayer, former CEO and current Executive Chairman of Dexcom, to its board of directors effective November 2, 2026, expanding the board to 11 members. Sayer brings decades of medtech leadership, having led Dexcom as CEO from 2015 to 2026 and served as its Chairman since 2018. Separately, Robert A. Parks was appointed Chief Accounting Officer, bringing CAO experience from Fortrea, NetApp, Syneos Health, and IQVIA.
Key figures
- Board size
- 11
- Director initial rsu award usd
- 500000
- Director cash retainer usd per year
- 60000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.